Europe — EMA

Paclitaxel-Gry

Paclitaxel, the active ingredient in Paclitaxel-Gry, is a chemotherapy agent presented as a sterile injectable solution for intravenous use.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel-Gry, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It is employed in the treatment of various solid tumours and is administered under the supervision of oncologists.

GNH USA supplies Paclitaxel-Gry as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Paclitaxel used for?

Paclitaxel is a mitotic inhibitor that interferes with micro‑cellular processes of the cell division cycle in solid tumours across a range of cancers.

- Breast cancer: Improves the ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - ... … ... ... … ... ... … ... ... ... ... ... … ... … ... … ... … ... ... ... ... - … … … … ... ... … ...

What are the side effects of Paclitaxel?

The ... … … .... ... ... ......

What precautions apply to Paclitaxel?

...

What does Paclitaxel interact with?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →